INVARIANT LLC

Lobbying for KERECIS · Biotechnology company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $70,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.